{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-003245","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2025-04-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.513785+00:00","generated_at":"2026-05-23T19:12:30.322397+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Mangoceuticals issues 590,000 common shares on conversions of preferred stock and debt","bullets":["March 28: 350 Series B Convertible Preferred shares (stated value $385,000) converted into 256,666 common shares at $1.50/share.","April 2: MAAB Global Ltd. converted $500,000 of debt into 333,333 common shares at $1.50/share.","Issuances exempt under Section 3(a)(9) as exchanges with existing holders; no commission paid."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-003245","json":"https://secwatch.observer/filing/0001641172-25-003245.json","markdown":"https://secwatch.observer/filing/0001641172-25-003245.md","text":"https://secwatch.observer/filing/0001641172-25-003245.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000164117225003245/0001641172-25-003245-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000164117225003245/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T19:12:30.322397+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}